Insmed (INSM) Current Leases (2010 - 2026)
Insmed (INSM) posted quarterly Current Leases of $3.4 million for Q1 2026, up 12.84% year-over-year from $3.1 million in Q1 2025, and up 3.02% quarter-over-quarter from $3.3 million in Q4 2025.
Analysis
Insmed (INSM) Current Leases (2010 - 2026) Analysis & Trends
Insmed's Current Leases history runs 13 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- In Q1 2026, Current Leases rose 12.84% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 12.84% YoY), while the FY2025 annual figure was $3.3 million, down 64.26% from the prior year.
- Current Leases for Q1 2026 stood at $3.4 million, up from $3.3 million in the prior quarter.
- The five-year high for Current Leases was $9.6 million in Q1 2022, with the low at $337000.0 in Q3 2022.
- The 5-year median for Current Leases is $3.3 million (2025), against an average of $4.3 million.
- Peak annual rise in Current Leases reached 760.14% in 2022, while the deepest fall reached 87.23% in 2022.
- Insmed's Current Leases stood at $1.2 million in 2022, then soared by 559.98% to $8.0 million in 2023, then advanced by 16.51% to $9.4 million in 2024, then sank by 64.26% to $3.3 million in 2025, then advanced by 3.02% to $3.4 million in 2026.
- Business Quant data shows INSM's Current Leases at $3.4 million in Q1 2026, $3.3 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn | 4.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.27 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 9.47 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 9.36 Mn |
| Sep 30, 2024 | 7.63 Mn |
| Jun 30, 2024 | 6.08 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Sep 30, 2023 | 6.42 Mn |
| Jun 30, 2023 | 4.16 Mn |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | 6.91 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 5.04 Mn |
| Mar 31, 2022 | 9.63 Mn |
| Dec 31, 2021 | 9.53 Mn |
| Sep 30, 2021 | 5.95 Mn |